Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Macular Drusen Evolution in Patients With Intermediate Age-related Macular Degeneration (AMD) Taking Oral Food Supplementation: an Open-label,Single-arm Pilot Study
Authors not listed
Laboratoires Thea · 2021
Abstract
LT7082-001 is an open-label, single-arm pilot study. Patients with intermediate age-related macular degeneration (AMD) wil take T7082 during 12 months , an association of 4 food supplementations .
The study objectives are to describe morphological changes and evolution of drusen in macula after a 12-month of food supplementation and to assess the safety of T7082
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-02 MST
Cite this
APA
Anonymous. (2021). Macular Drusen Evolution in Patients With Intermediate Age-related Macular Degeneration (AMD) Taking Oral Food Supplementation: an Open-label,Single-arm Pilot Study. <em>Laboratoires Thea</em>. https://clinicaltrials.gov/study/NCT04778436
Vancouver
Anonymous. Macular Drusen Evolution in Patients With Intermediate Age-related Macular Degeneration (AMD) Taking Oral Food Supplementation: an Open-label,Single-arm Pilot Study. Laboratoires Thea. 2021.
BibTeX
@misc{anon2021Macula,
title = {Macular Drusen Evolution in Patients With Intermediate Age-related Macular Degeneration (AMD) Taking Oral Food Supplementation: an Open-label,Single-arm Pilot Study},
author = {Anonymous},
journal = {Laboratoires Thea},
year = {2021},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Survey of Ophthalmology 1999
Citation only
Drusen in Age-Related Macular Degeneration
Eye 1994
Citation only
Evolution of soft drusen in age-related macular degeneration
Ophthalmology 1994
Citation only
Bilateral Macular Drusen in Age-related Macular Degeneration
ClinOmicsAI 2025
Open access · US-GOV
A Phase 1, Single-Center, Prospective Study to Evaluate the Safety and Clinical Utility of Anterior Chamber Paracentesis for Proteomic Analysis in Patients With Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
Institut de la Macula y la Retina 2020
Open access · US-GOV
A PILOT STUDY TO EVALUATE THE PROGRESSION OF THE DISEASE AND RESPONSE TO SUPPLEMENTATION WITH POSTBIOTICS IGEN-0222 IN PATIENTS WITH MACULAR DEGENERATION
Peking University 2010
Open access · US-GOV